Vimarsana
Biggest News Aggregation in the World

Page 44 - Technology Commercialization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technology Commercialization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technology Commercialization Today - Breaking & Trending Today

Ohio State VP Grace Wang to leave for Worcester Polytechnic Institute - Vimarsana News

Ohio State VP Grace Wang to leave for Worcester Polytechnic Institute

Grace Wang was hired in 2020 to reorganize of Ohio State's technology research enterprises. Her tenure led to some of OSU's major tech funding gains.

Researchers are working to make wind turbines capture carbon dioxide and use it for cement - Vimarsana News

Researchers are working to make wind turbines capture carbon dioxide and use it for cement

New research into wind turbines claims they might be able to remove carbon dioxide from the atmosphere - and use it to make cement.

DOST-V creates iWOMEN, a program to support women micro-entrepreneurs in Bicol - Vimarsana News

DOST-V creates iWOMEN, a program to support women micro-entrepreneurs in Bicol

The Department of Science and Technology - Region V has created a program that aims to support women micro-entrepreneurs (WMEs) in the Bicol Region. Dr. Luis O. Amano (from left), BU Vice President for Research, Development & Extension; DOST-V Regional Director Mr. Rommel R. Serrano; and Dr.

Source: mb.com.ph
Growth Vs. Value Stock Investing: How They Compare - Vimarsana News

Growth Vs. Value Stock Investing: How They Compare

Historically, growth stocks perform best when interest rates are low, while value stocks tend to outperform during economic downturns.

UT Southwestern Ranked No. 1 in Texas, Fourth in Nation for Tech Transfer - Vimarsana News

UT Southwestern Ranked No. 1 in Texas, Fourth in Nation for Tech Transfer

UT Southwestern Medical Center ranked fourth in the nation and No. 1 in Texas for commercializing new biomedical technologies